Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective— Smooth muscle cell (SMC) proliferation within the intima is regulated by heparan sulfates. We studied a low molecular weight (LMW) fucoidan (sulfated polysaccharide from brown seaweed) on SMC proliferation in vitro and intimal hyperplasia in vivo. Methods and Results— In vitro study revealed that LMW fucoidan reduces rabbit SMC proliferation and is internalized in SMC perinuclear vesicles. On rabbit iliac arteries perfused in vivo with fluorolabeled LMW fucoidan after angioplasty, the labeling was mainly located on sites of injury. Pharmacokinetic studies showed that LMW fucoidan exhibited in rats an elimination half-life of 56±25 minutes (n=8) after intravenous administration and a constant plasma rate for ≥6 hours after intramuscular administration. After stent implantation in their iliac arteries, rabbits were also treated with LMW fucoidan (5 mg/kg IM twice a day). Histomorphometric analysis at day 14 indicated that LMW fucoidan reduced intimal hyperplasia by 59% (1.79±0.4 versus 0.73±0.2 mm 2 , P <0.0001) and luminal cross-sectional area narrowing by 58% (0.38±0.08 versus 0.16±0.04, P <0.0001). Blood samples showed no anticoagulant activity due to LMW fucoidan. Conclusions— This natural polysaccharide with high affinity for SMCs and sustained plasma concentration markedly reduced intimal hyperplasia, suggesting its use for the prevention of human in-stent restenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and Anticoagulant Activity of Sulfated Fucans
Pereira, M. S., Mulloy, B., & Mourão, P. A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7656 · Cited by 377
Further data on the structure of brown seaweed fucans: relationships with anticoagulant activity
Chevolot, L., Foucault, A., Chaubet, F., Kervarec, N., Sinquin, C., Fisher, A.-M., & Boisson-Vidal, C. (1999) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00127-5 · Cited by 330
Cited by
Fucoidan: Structure and bioactivity
Li, B., Lu, F., Wei, X., & Zhao, R. (2008) · Molecules · doi:10.3390/molecules13081671 · Cited by 1,383
Therapies from Fucoidan; Multifunctional Marine Polymers
Fitton, J. H. (2011) · Marine Drugs · doi:10.3390/md9101731 · Cited by 392
Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Atashrazm, F., Lowenthal, R., Woods, G., Holloway, A., & Dickinson, J. (2015) · Marine Drugs · doi:10.3390/md13042327 · Cited by 358
Structure, biology, evolution, and medical importance of sulfated fucans and galactans
Pomin, V. H., & Mourao, P. A. S. (2008) · Glycobiology · doi:10.1093/glycob/cwn085 · Cited by 356
“After perfusion of iliac arteries of rabbits with fluoro-labeled sulfated fucans, the labeling is mainly localized on the sites of injury (Deux et al. 2002).”
MethodWillcox, D. C., Willcox, B. J., Todoriki, H., & Suzuki, M. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718117 · Cited by 311
Metadata
- Authors
- Deux, J.-F., Meddahi-Pellé, A., Le Blanche, A. F., Feldman, L. J., Colliec-Jouault, S., Brée, F., Boudghène, F., Michel, J.-B., & Letourneur, D.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2002-10
- Volume
- 22
- Issue
- 10
- Pages
- 1604-1609
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2134919787
- Cited by
- 95
- References
- 2
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model. https://app.cochat.ai/papers/10.1161/01.atv.0000032034.91020.0a
- The paper
- Deux, J.-F., Meddahi-Pellé, A., Le Blanche, A. F., Feldman, L. J., Colliec-Jouault, S., Brée, F., Boudghène, F., Michel, J.-B., & Letourneur, D. (2002). Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000032034.91020.0a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.